Cargando…

Uses of Vascular Endothelial Growth Factor C as a Lung Adenocarcinoma Prognostic Biomarker

BACKGROUND: Lung adenocarcinoma (LUAD) is the most common type of lung cancer and a leading cause of death worldwide. Vascular endothelial growth factor C (VEGF-C) has been identified as a prognosis prediction marker for LUAD. However, VEGF-C protein expression does not appear to significantly relat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Shi, Pan, Ting Yu, Wu, Xiao, Li, Tian, Wei, Yu, He, Hai Lang, Zhou, Xian Mei, Wang, Qian, Zhu, Ji Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990733/ https://www.ncbi.nlm.nih.gov/pubmed/36896001 http://dx.doi.org/10.14740/wjon1520

Ejemplares similares

Overexpression of hsa_circ_0001715 is a Potential Diagnostic and Prognostic Biomarker in Lung Adenocarcinoma
por: Lu, Guo-jun, et al.
Publicado: (2020)

GGT5 Is an Independent Prognostic Biomarker in Stomach Adenocarcinoma
por: Huang, Yong, et al.
Publicado: (2022)

Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma
por: Ying, Junjie, et al.
Publicado: (2023)

Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma
por: Wang, Jinn-Li, et al.
Publicado: (2018)

Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma
por: Huo, Chen, et al.
Publicado: (2020)

EFCC1 as a putative prognostic biomarker in lung adenocarcinoma
por: Yu, Shengnan, et al.
Publicado: (2020)

Comprehensive analysis of the oncogenic roles of vascular endothelial growth factors and their receptors in stomach adenocarcinoma
por: Li, Jianxin, et al.
Publicado: (2023)

Vascular endothelial growth factor A is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma
por: Qi, Yuchen, et al.
Publicado: (2023)

ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma
por: Yang, Wendi, et al.
Publicado: (2023)

Carboxypeptidase N2 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma
por: Xu, Ting, et al.
Publicado: (2022)

Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma
por: Amano, Takahiro, et al.
Publicado: (2021)

Biomarkers for anti-vascular endothelial growth factor drugs
por: Kuriyama, Sho, et al.
Publicado: (2022)

Spondin2 is a new prognostic biomarker for lung adenocarcinoma
por: Yuan, Xiaopeng, et al.
Publicado: (2017)

Prognostic Value of Inflammatory Biomarkers in Patients With Stage I Lung Adenocarcinoma Treated With Surgical Dissection
por: Shen, Yu-Jia, et al.
Publicado: (2021)

CBX7, a Potential Prognostic Biomarker in Lung Adenocarcinoma
por: Yang, Yanlong, et al.
Publicado: (2021)

The effects of the prognostic biomarker SAAL1 on cancer growth and its association with the immune microenvironment in lung adenocarcinoma
por: Tong, Song, et al.
Publicado: (2023)

Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients
por: Li, Yun-Fei, et al.
Publicado: (2022)

N6-Methyladenosine-Regulated mRNAs: Potential Prognostic Biomarkers for Patients With Lung Adenocarcinoma
por: Sun, Junjun, et al.
Publicado: (2021)

STARD12/14 are diagnostic and prognostic biomarkers of lung adenocarcinoma associated with epigenetic regulation, immune infiltration and ferroptosis
por: Zhang, Wen-Di, et al.
Publicado: (2023)

RS1 gene is a novel prognostic biomarker for lung adenocarcinoma
por: Zhang, Tao, et al.
Publicado: (2022)

LHX3 is an early stage and radiosensitivity prognostic biomarker in lung adenocarcinoma
por: Lin, Xin, et al.
Publicado: (2017)

ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma
por: Zheng, Yu-Zhu, et al.
Publicado: (2016)

Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma
por: Yuan, Yinjiao, et al.
Publicado: (2023)

The Evaluation of Vascular Endothelial Growth Factor A (VEGFA) and VEGFR2 Receptor as Prognostic Biomarkers in Bladder Cancer
por: El Azzouzi, Meryem, et al.
Publicado: (2023)

GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma
por: Han, Jiahui, et al.
Publicado: (2021)

SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma
por: Huang, Hui, et al.
Publicado: (2021)

Vascular Endothelial Growth Factor Accelerates Compensatory Lung Growth by Increasing Alveolar Units
por: Dao, Duy T., et al.
Publicado: (2018)

LIPG is a novel prognostic biomarker and correlated with immune infiltrates in lung adenocarcinoma
por: Wang, Shan, et al.
Publicado: (2022)

Sanguinarine Inhibits Vascular Endothelial Growth Factor Release by Generation of Reactive Oxygen Species in MCF-7 Human Mammary Adenocarcinoma Cells
por: Dong, Xian-zhe, et al.
Publicado: (2013)

Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer
por: Li, Jian, et al.
Publicado: (2014)

A novel long noncoding RNA AC092718.4 as a prognostic biomarker and promotes lung adenocarcinoma progression
por: Chen, Siqin, et al.
Publicado: (2022)

GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma
por: Song, Shimao, et al.
Publicado: (2022)

AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma
por: Ma, Chenxi, et al.
Publicado: (2020)

Serum Soluble Vascular Endothelial Growth Factor Receptor 1 as a Potential Biomarker of Hepatopulmonary Syndrome
por: Li, Yu-Jie, et al.
Publicado: (2023)

SPP1 and AGER as potential prognostic biomarkers for lung adenocarcinoma
por: Zhang, Weiguo, et al.
Publicado: (2018)

Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis
por: Hou, Jili, et al.
Publicado: (2021)

KLRK1 as a prognostic biomarker for lung adenocarcinoma cancer
por: Zhang, Yanan, et al.
Publicado: (2022)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
por: Tu, Zhengliang, et al.
Publicado: (2021)

NMU Is a Poor Prognostic Biomarker in Patients with Lung Adenocarcinoma
por: Tang, Yan, et al.
Publicado: (2021)

Transcription Factor MAFB as a Prognostic Biomarker for the Lung Adenocarcinoma
por: Samir, Omar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7n4opprik6nu3lpe6b78erar25